The next forum for unraveling FDA off-label marketing rules: State and federal legislatures

by Michael S. Sinha, Aaron S. Kesselheim In a Guest Editorial, Aaron S. Kesselheim and Michael S. Sinha show how federal and state legislation to allow promotion of drugs for non-approved uses threatens to undermine the FDA's public health mission.
Source: PLoS Medicine - Category: Internal Medicine Authors: Source Type: research